EZZ Life Science Holdings Limited

A$0.30As of Sun 8 Nov 2026, 12:00 UTC
ASX:EZZHealthcare
Country Australia
PE (Fwd) •••
TSR 6Y CAGR (12.66%)
Div yield 6.67%
ROE (20.25%)
Biotechnology
Beta (5Y) 1.15
PE TTM —
TSR TTM (86.55%)
Mkt cap A$14.12M
ROIC (46.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.374
24.59%
(17.97%)
Hold 3|8|12|0|0
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
20.04%
17.74%
3.75%
3.28%
Revenue$M
0.960
1.017
1.053
1.094
6.93%
8.53%
10.78%
11.93%
Peers (US$9.698M)
Cap (US$)
PE
9.467M
—
8.797M
—
9.614M
—
Capital
TTM
5Y
10Y
Leveragex
1.729
0.116
0.085
EBIT/Intx
0.552
0.546
0.532
Own earn%
(81.55)
(13.90)
(15.20)
Sh yield%
33.66
46.19
44.81
Owners
Insiders/Inst%
10.27
52.65
Short interest%
0.89
SBC / revenue%
4.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
20–31
$1 testx
1.0
Incr. ROIC%
3